Abstract
Down syndrome is the commonest chromosomal disorder causing mild to moderate intellectual disability, yet it is one of the neglected disorder amongst practicing physicians. Children with Down syndrome when intervened early by speech therapy, physiotherapy and occupational therapy and given proper medical attention for different health issues, can have a better long term outcome as compared to other genetic causes of intellectual disability. This paper would help the general practitioners to identify children with Down syndrome and to manage the common problems associated with this condition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Styles ME, Cole TJ, Dennis J, Preece MA. New cross sectional stature, weight, and head circumference references for Down’s syndrome in the UK and Republic of Ireland. Arch Dis Child. 2002;87:104–8.
Bull MJ. Committee on genetics. Health supervision for children with Down syndrome. Pediatrics. 2011;128:393–406.
Weijerman ME, de Winter JP. Clinical practice. The care of children with Down syndrome. Eur J Pediatr. 2010;169:1445–52.
Carter JC, Capone GT, Gray RM, Cox CS, Kaufmann WE. Autistic-spectrum disorders in Down syndrome: Further delineation and distinction from other behavioral abnormalities. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:87–94.
Molloy C, Murray S, Kinsman A, Castillo H, Mitchell T, Hickey FJ, et al. Differences in the clinical presentation of trisomy 21 with and without autism. J Intellect Disabil Res. 2009;53:143–51.
Hunter AGW. Down syndrome. In: Cassidy SB, Allanson JE, eds. Management of Genetic Syndromes. 3rd ed. USA: Wiley Blackwell; 2010.
ACOG Committee on Practice Bulletins. ACOG practice bulletin No. 77: Screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109:217–27.
American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 88: Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110:1459–67.
Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn. 2013;33:622–9.
Malec E, Mroczek T, Pajak J, Januszewska K, Zdebska E. Results of surgical treatment of congenital heart defects in children with Down’s syndrome. Pediatr Cardiol. 1999;20:351–4.
Bhatia S, Verma IC, Shrivastava S. Congenital heart disease in Down syndrome: An echocardiographic study. Indian Pediatr. 1992;29:1113–6.
Nahar R, Kotecha U, Puri RD, Pandey RM, Verma IC. Survival analysis of down syndrome cohort in a tertiary health care center in India. Indian J Pediatr. 2013;80:118–23.
Masuda M, Kado H, Tanoue Y, Fukae K, Onzuka T, Shiokawa Y, et al. Does Down syndrome affect the long-term results of complete atrioventricular septal defect when the defect is repaired during the first year of life? Eur J Cardiothorac Surg. 2005;27:405–9.
Bhat AS, Chaturvedi MK, Saini S, Bhatnagar S, Gupta N, Sapra S, et al. Prevalence of celiac disease in Indian children with Down syndrome and its clinical and laboratory predictors. Indian J Pediatr. 2013;80:114–7.
Hankinson TC, Anderson RC. Craniovertebral junction abnormalities in Down syndrome. Neurosurgery. 2010;66:A32–8.
Salman M. Systematic review of the effect of therapeutic dietary supplements and drugs on cognitive function in subjects with Down syndrome. Eur J Paediatr Neurol. 2002;6:213–9.
Kishnani PS, Heller JH, Spiridigliozzi GA, Lott I, Escobar L, Richardson S, et al. Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10–17. Am J Med Genet A. 2010;152A:3028–35.
Heller JH, Spiridigliozzi GA, Crissman BG, McKillop JA, Yamamoto H, Kishnani PS. Safety and efficacy of rivastigmine in adolescents with Down syndrome: Long-term follow-up. J Child Adolesc Psychopharmacol. 2010;20:517–20.
Mohan M, Carpenter PK, Bennett C. Donepezil for dementia in people with Down syndrome. Cochrane Database Syst Rev. 2009;1:CD007178.
Sheets KB, Crissman BG, Feist CD, Sell SL, Johnson LR, Donahue KC, et al. Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: Recommendations of the national society of genetic counselors. J Genet Couns. 2011;20:432–41.
Skotko BG, Capone GT, Kishnani PS. Postnatal diagnosis of down syndrome: Synthesis of the evidence on how best to deliver the news. Pediatrics. 2009;124:e751.
Gardner RJM, Sutherland GR. Chromosome abnormalities and genetic counseling. 3rd ed. New York: Oxford University Press, Inc; 2004.
Harper PS. Practical genetic counselling. 6th ed. London: Edward Arnold, Ltd; 2004.
Acknowledgments
The authors thank Dr Shubha Phadke, SGPGI, Lucknow for her invaluable comments. They also thank Dr Savita Sapra, Child Psychologist, Division of Genetics, AIIMS and Dr Shanti Aulluck, President and Director, Muskaan, NGO, New Delhi for their inputs.
Conflict of Interest
None.
Role of Funding Source
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editor: Bhim S. Pandhi
Rights and permissions
About this article
Cite this article
Agarwal Gupta, N., Kabra, M. Diagnosis and Management of Down Syndrome. Indian J Pediatr 81, 560–567 (2014). https://doi.org/10.1007/s12098-013-1249-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-013-1249-7